Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind,Vehicle-Controlled Study to Determine the Efficacy and Safety of AP0302 in the Treatment of Delayed Onset Muscle Soreness (DOMS)

NCT03852459 is registered in ClinicalTrials.gov with Aponia Laboratories, Inc. as lead sponsor.

NCT NCT03852459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03852459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind,Vehicle-Controlled Study to Determine the Efficacy and Safety of AP0302 in the Treatment of Delayed Onset Muscle Soreness (DOMS)
Lead sponsor
Aponia Laboratories, Inc.
Phase
Phase 2
Overall status
Completed
Start date
January 12, 2018
Completion date
April 11, 2019
Enrollment
251 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain, acute